Bayesian Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,800	Closed	-$1.13M	–	168
2025 Q3	$1.13M	Buy	20,800 +10,400	+100%	+$595K	0.23%	139
2025 Q2	$572K	Sell	10,400 -23,700	-70%	-$1.4M	0.09%	257
2025 Q1	$2.41M	Buy	34,100 +23,000	+207%	+$1.55M	0.4%	66
2024 Q4	$730K	Sell	11,100 -9,722	-47%	-$651K	0.09%	298
2024 Q3	$1.46M	Buy	+20,822	New	+$1.74M	0.17%	178
2023 Q1	–	Sell	-20,304	Closed	-$2.1M	–	794
2022 Q4	$2.1M	Buy	+20,304	New	+$1.91M	0.31%	59
2021 Q1	–	Sell	-2,419	Closed	-$212K	–	540
2020 Q4	$212K	Sell	2,419 -401	-14%	-$31.8K	0.06%	371
2020 Q3	$215K	Buy	+2,820	New	+$285K	0.05%	428
2017 Q3	–	Sell	-5,200	Closed	-$472K	–	482
2017 Q2	$472K	Buy	+5,200	New	+$473K	0.17%	196